Correction (DOI:10.1016/j.jvs.2008.11.070);The benefit of statins in non-cardiac vascular surgery patients

Journal of Vascular Surgery

Volumn 49, Issue 1, 2009, Pages 260-265

  Stalenhoef, Anton F H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; EDIFOLIGIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN;

ABDOMINAL AORTA ANEURYSM; ANEURYSM SURGERY; ARTERY CATHETERIZATION; ARTERY DISEASE; ARTERY RECONSTRUCTION; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; DOSE RESPONSE; DRUG DOSE INCREASE; HUMAN; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVASCULARIZATION; SURGICAL PATIENT; SURVIVAL; TREATMENT OUTCOME; TREATMENT RESPONSE; VASCULAR SURGERY;

EID: 58449109405     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2009.01.056     Document Type: Erratum

References (33)

1. [No authors listed]. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344 (1994) 1383-1389
2. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360 (2002) 7-22
3. Baigent C., Keech A., Kearney P.M., Blackwell L., Buck G., Pollicino C., et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366 (2005) 1267-1278
4. Robinson J.G., Smith B., Maheshwari N., and Schrott H. Pleiotropic effects of statins: benefit beyond cholesterol reduction?. A meta-regression analysis. J Am Coll Cardiol 46 (2005) 1855-1862
5. Wanner C., Krane V., März W., Olschewski M., Mann J.F., Ruf G., et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353 (2005) 238-248
6. Kjekshus J., Apetrei E., Barrios V., Böhm M., Cleland J.G., Cornel J.H., et al. Rosuvastatin in older patients with systolic heart failure. N Engl J Med 357 (2007) 2248-2261
7. [No authors listed]. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 348 (1996) 1329-1339
8. Pedersen T.R., Kjekshus J., Pyörälä K., Olsson A.G., Cook T.J., Musliner T.A., et al. Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S). Am J Cardiol 81 (1998) 333-335
9. Amarenco P., Bogousslavsky J., Callahan III A., Goldstein L.B., Hennerici M., Rudolph A.E., et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 355 (2006) 549-559
10. Paraskevas K.I., Hamilton G., and Mikhailidis D.P. Statins: an essential component in the management of carotid artery disease. J Vasc Surg 46 (2007) 373-386
11. Feringa H.H., Karagiannis S.E., van Waning V.H., Boersma E., Schouten O., Bax J.J., and Poldermans D. The effect of intensified lipid-lowering therapy on long-term prognosis in patients with peripheral arterial disease. J Vasc Surg 45 (2007) 936-943
12. Schanzer A., Hevelone N., Owens C.D., Beckman J.A., Belkin M., and Conte M.S. Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia. J Vasc Surg 47 (2008) 774-781
13. O'Neil-Callahan K., Katsimaglis G., Tepper M.R., Ryan J., Mosby C., Ioannidis J.P., and Danias P.G. Statins decrease perioperative cardiac complications in patients undergoing non-cardiac vascular surgery: the Statins for Risk Reduction in Surgery (StaRRS) study. J Am Coll Cardiol 45 (2005) 336-342
14. Poldermans D., Bax J.J., Kertai M.D., Krenning B., Westerhout C.M., Schinkel A.F., et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 107 (2003) 1848-1851
15. van Gestel Y.R., Hoeks S.E., Sin D.D., Simsek C., Welten G.M., Schouten O., et al. Effect of statin therapy on mortality in patients with peripheral arterial disease and comparison of those with versus without associated chronic obstructive pulmonary disease. Am J Cardiol 102 (2008) 192-196
16. Heart Protection Study Collaborative Group. Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg 45 (2007) 645-654 discussion 653-4
17. Biccard B.M. A peri-operative statin update for non-cardiac surgery. Part II: statin therapy for vascular surgery and peri-operative statin trial design. Anaesthesia 63 (2008) 162-171
18. van Wissen S., Trip M.D., Smilde T.J., de Graaf J., Stalenhoef A.F., and Kastelein J.J. Differential hs-CRP reduction in patients with familial hypercholesterolemia treated with aggressive or conventional statin therapy. Atherosclerosis 165 (2002) 361-366
19. Kennedy J., Quan H., Buchan A.M., Ghali W.A., and Feasby T.E. Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients. Stroke 36 (2005) 2072-2076
20. McGirt M.J., Perler B.A., Brooke B.S., Woodworth G.F., Coon A., Jain S., et al. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy. J Vasc Surg 42 (2005) 829-836
21. Brooke B.S., McGirt M.J., Woodworth G.F., Chang D.C., Roseborough G.S., Freischlag J.A., and Perler B.A. Preoperative statin and diuretic use influence the presentation of patients undergoing carotid endarterectomy: results of a large single-institution case-control study. J Vasc Surg 45 (2007) 298-303
22. Kertai M.D., Boersma E., Westerhout C.M., van Domburg R., Klein J., Bax J.J., et al. Association between long-term statin use and mortality after successful abdominal aortic aneurysm surgery. Am J Med 116 (2004) 96-103
23. Sukhija R., Aronow W.S., Sandhu R., Kakar P., and Babu S. Mortality and size of abdominal aortic aneurysm at long-term follow-up of patients not treated surgically and treated with and without statins. Am J Cardiol 97 (2006) 279-280
24. Schouten O., van Laanen J.H., Boersma E., Vidakovic R., Feringa H.H., Dunkelgrün M., et al. Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth. Eur J Vasc Endovasc Surg 32 (2006) 21-26
25. Mosorin M., Niemelä E., Heikkinen J., Lahtinen J., Tiozzo V., Satta J., et al. The use of statins and fate of small abdominal aortic aneurysms. Interact Cardiovasc Thorac Surg 7 (2008) 578-581
26. Schlösser F.J., Tangelder M.J., Verhagen H.J., van der Heijden G.J., Muhs B.E., van der Graaf Y., et al. Growth predictors and prognosis of small abdominal aortic aneurysms. J Vasc Surg 47 (2008) 1127-1133
27. McDermott M.M., Guralnik J.M., Greenland P., Pearce W.H., Criqui M.H., Liu K., et al. Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease. Circulation 107 (2003) 757-761
28. Mohler III E.R., Hiatt W.R., and Creager M.A. Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease. Circulation 108 (2003) 1481-1486
29. Mondillo S., Ballo P., Barbati R., Guerrini F., Ammaturo T., Agricola E., et al. Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease. Am J Med 114 (2003) 359-364
30. Schillinger M., Exner M., Mlekusch W., Amighi J., Sabeti S., Muellner M., et al. Statin therapy improves cardiovascular outcome of patients with peripheral artery disease. Eur Heart J 25 (2004) 742-748
31. Henke P.K., Blackburn S., Proctor M.C., Stevens J., Mukherjee D., Rajagopalin S., et al. Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are under prescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality. J Vasc Surg 39 (2004) 357-365
32. Abbruzzese T.A., Havens J., Belkin M., Donaldson M.C., Whittemore A.D., Liao J.K., and Conte M.S. Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts. J Vasc Surg 39 (2004) 1178-1185
33. Ward R.P., Leeper N.J., Kirkpatrick J.N., Lang R.M., Sorrentino M.J., and Williams K.A. The effect of preoperative statin therapy on cardiovascular outcomes in patients undergoing infrainguinal vascular surgery. Int J Cardiol 104 (2005) 264-268